UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of Report (Date of Earliest Event Reported): September 15, 2009
UDR, INC.
(Exact name of registrant as specified in charter)
|
|
|
|
|
Maryland
|
|
1-10524
|
|
54-0857512 |
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.) |
|
|
|
1745 Shea Center Drive, Suite 200, |
|
|
Highlands Ranch, Colorado
|
|
80129 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
Registrants telephone number, including area code: (720) 283-6120
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On September 15, 2009, UDR, Inc. (the Company) entered into a Sales Agreement (the Sales
Agreement) with Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co.
Incorporated, as sales agents and/or principals (the Agents). Under the terms of the Sales
Agreement, the Company may sell up to 15,000,000 shares of its common stock, from time to time, to
or through or the Agents. Sales of the shares, if any, will be made by means of ordinary brokers
transactions on the New York Stock Exchange at prevailing market prices at the time of sale, or as
otherwise agreed with the applicable Agent. The Company will pay each Agent compensation for sales
of the shares equal to 2% of the gross sales price per share of shares sold through such Agent, as
sales agent, under the Sales Agreement.
The Company is not obligated to sell and the Agents are not obligated to buy or sell any
shares under the Sales Agreement. No assurance can be given that the Company will sell any shares
under the Sales Agreement, or, if it does, as to the price or amount of shares that it sells, or
the dates when such sales will take place.
The shares will be offered pursuant to the Companys shelf registration statement on Form S-3
(Registration No. 333-156002), which became effective upon filing with the Securities and Exchange
Commission on December 8, 2008.
A copy of the Sales Agreement is attached hereto as Exhibit 1.1 and is incorporated by
reference herein. The foregoing description of the material terms of the Sales Agreement and the
transactions contemplated thereby does not purport to be complete and is qualified in its entirety
by reference to Exhibit 1.1.
Kutak Rock LLP, as counsel to the Company, has issued its opinion with respect to the legality
of the shares of common stock that may be issued pursuant to the Sales Agreement. The legality
opinion is included as Exhibit 5.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
|
|
Exhibit No. |
|
Description |
|
|
|
|
|
|
1.1 |
|
|
Sales Agreement dated September 15, 2009, among UDR, Inc., Merrill
Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated. |
|
|
|
|
|
|
5.1 |
|
|
Opinion of Kutak Rock LLP. |
|
|
|
|
|
|
23.1 |
|
|
Consent of Kutak Rock LLP (contained in Exhibit 5.1). |